Incidence of PCT (plateletcrit) decrease in COVID-19 positive patients – diagnostic and epidemiologic value
Abstract
Introduction: Platelets play an important role in the pathogenesis of COVID-19. Therefore, their parameters vary in different stages of the disease. The importance of plateletcrit in COVID-19 is not well known.
Objective: To examine the diagnostic value of plateletcrit in COVID-19.
Methods: From January to March and September-December 2021. during their initial visit to the COVID outpatient clinic at the Primary Healthcare Center Nis, we examined 440 patients who were experiencing possible COVID-19 symptoms. Following the examination, a complete blood count was performed, and they tested positive for COVID-19. We analyzed the plateletcrit in every lab sample collected during
their first visit. The control group consisted of 60 patients from the “green zone” from January to December 2021, as well as 48 patients from the pre-COVID period, before 2020.
Results: Lower plateletcrit was found in 48,4% of women and 63,3% of men in the first period. Out of the total of 111 patients, lower plateletcrit was found in 54,9%. in the second period lower plateletcrit was found in 72,2% of women and 85% of men. Out of the total number of 329 patients, lower plateletcrit was found in 78,7%. In the control
group, from the “green zone” lower plateletcrit was found in 8,3% of 60 patients, and no decrease in plateletcrit levels was observed in 48 patients from the pre-COVID-19 era.
Conclusion: Plateletcrit levels are decreased in many patients during their initial visit due to COVID-19. Symptoms. Therefore, variations in plateletcrit levels could raise
concerns about potential COVID-19 infection
References
Khismatullin RR, Ponomareva AA, Nagaswami C, Ivaeva RA, Montone KT, Weisel JW, et al. Pathology of lung-specific thrombosis and inflammation in COVID-19. J Thromb Haemost 2021; 19(12): 3062–72
Flaumenhaft R, Enjyoji K, Schmaier AA. Vasculopathy in COVID-19. Blood 2022; 140(3): 222–35.
Barçın C. Thrombosis in COVID-19: We still need to learn a lot. Anatol J Cardiol 2021; 25(9): 600.
Andrade BS, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Freitas ADS, et al. Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms. Viruses 2021; 13(4): 700.
Miesbach W, Makris M. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clin Appl Thromb Hemost. 2020; 26: 1076029620938149.
Katneni UK, Alexaki A, Hunt RC, Schiller T, DiCuccio M, Buehler PW, et al. Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus. Thromb Haemost 2020; 120(12): 1668–79.
Al-Samkari H, Leaf RSK, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, et al. COVID 19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 2020; 136(4): 489–500.
Castro RA, Frishman WH. Thrombotic Complications of COVID-19 Infection: A Review. Cardiol Rev 2021; 29(1): 43–7.
Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 2020; 18(7): 1738–42. doi:10.1111/jth.14850. Epub 2020 Jun 24.PMID: 32302438
Lazzaroni MG, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A, et al. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev 2021; 46: 100745. doi:10.1016/j.blre.2020.100745. Epub 2020 Aug 24.
Khandelwal G, Ray A, Sethi S, Harikrishnan HK, Khandelwal C, Sadasivam B. COVID-19 and thrombotic complications-the role of anticoagulants, antiplatelets and thrombolytics. J Family Med Prim Care 2021; 10(10): 3561–7. doi:10.4103/jfmpc.jfmpc_1297_20. Epub 2021 Nov 5.
Bežovan D. Uzroci trombocitopenije u Covid-19 bolesnika. Diplomski rad. Sveučilište u Zagrebu, Medicinski fakultet, 2021. Dostupno na: https://repozitorij.mef.unizg.hr/islandora/object/mef:3966
Pranata R, Lim MA, Yonas E, Huang I, Nasution SA, Setiati S, et al. Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis. Epidemiol Infect 2021; 149: e40.
Mansoori et al., “Association between Biochemical and Hematologic Factors with COVID-19 Using Data Mining Methods.” BMC Infect Dis. 2023 Dec 21;23(1):897.doi: 10.1186/s12879-023-08676-0.
Gadó K, Kovács AK, Domján G, Nagy ZZ, Bednárik GD. COVID-19 and the elderly. Physiol Int. Published online May 16, 2022. doi:10.1556/2060.2022.00203
Singhal S, Kumar P, Singh S, Saha S, Dey AB. Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):321. doi:10.1186/s12877-021-02261-3
Copyright (c) 2024 Dalibor Jevtić, Slavoljub Janković, Danijela Marković, Milena Jevtić, Milan Đorđević, Aleksa Janković
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Autori zadržavaju autorska prava nad objavljenim člancima, a izdavaču daju neekskluzivno pravo da članak objavi, da u slučaju daljeg korišćenja članka bude naveden kao njegov prvi izdavač, kao i da distribuira članak u svim oblicima i medijima.